Covaxin demonstrates persistence of immunity and impact of third dose of inactivated COVID-19…
Subjects were evaluated for safety, neutralising antibody responses against variants of concern, binding antibodies against spike…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bharat Biotech
Ocugen announces positive results for COVID-19 vaccine trial for children aged two-18 years
Ocugen’s partner Bharat Biotech’s phase-II/III study of Covaxin (BBV152) in 526 children showed safety, efficacy, and superior…
ICMR study finds Covaxin booster dose improves effectiveness against Delta, Omicron variants
The antibody response, clinical observations, viral load reduction and lung disease severity after virus challenge were observed…
US FDA lifts hold on Covaxin’s clinical trials
The FDA's earlier decision, in April, to put on hold the trials was based on the US firm's decision to voluntarily implement a…
CEPI partners with consortium of Bharat Biotech, University of Sydney and ExcellGene to develop…
CEPI will fund the researchers to conduct activities including immunogen design, pre-clinical studies, manufacturing process…
Bharat Biotech seeks DCGI nod for phase-II/III Covaxin booster trial
The study is likely to be conducted at six sites, including AIIMS Delhi and Patna
Bharat Biotech must address WHO’s Covaxin supply suspension to avoid EUL cancellation, says…
In a communication to Dr V K Paul, Member (health), NITI Aayog, Ministry of External Affairs (MEA) said many issues about vaccines…
DCGI approves three COVID vaccines for kids aged above five years
The approval has been granted to Covaxin, ZyCov-D and Corbevax
Covaxin booster enhances antibody response against COVID variants: Study
The study was conducted in January and the findings were published in the "Journal of Travel Medicine" on 24th March
Covaxin to cost Rs 225 per dose for private hospitals
Fresh stocks of Covaxin are available and ready for supplies